Skip to main content

Table 1 Summary of patient characteristics

From: Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Characteristic

Number

Percent

Age (years)

median: 56

range: 27–78

  < 60

49

65.3

  > 60

26

34.7

Sex

 Male

40

53

 Female

35

47

Localization of primary

 Pancreas

50

66.6

 Midgut

11

14.6

 Bronchus

6

8

 Stomach

1

1.3

 Hindgut

2

2.6

 Thymus

1

1.3

 Unknown

4

5.3

Tumor grading

 G1

27

36

 G2

34

45

 Unspecified

14

19

Prior treatment

 1 prior treatment

24

32

  > 1 prior treatment

43

57

 No pretreatment

4

5.3

 No data available

4

5.3

Metastases

 No metastases (locally advanced)

2

2.6

 Liver only

33

44

 Liver plus additional

 Extrahepatic metastases

 (Bone, lung, spleen)

40

53